CA Stock MarketDetailed Quotes
GTTX GeneTether Therapeutics Inc
- 0.035
- 0.0000.00%
15min DelayMarket Closed Dec 4 10:31 ET
1.36MMarket Cap-2.50P/E (TTM)
0.000High0.000Low0Volume0.000Open0.035Pre Close0.00Turnover0.11052wk High0.00%Turnover Ratio38.74MShares0.01552wk Low-0.014EPS TTM304.95KFloat Cap0.680Historical HighLossP/E (Static)8.71MShs Float0.005Historical Low-0.013EPS LYR0.00%Amplitude--Dividend TTM0.97P/B1Lot Size--Div YieldTTM
GeneTether Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -29.04%966.11K | -28.07%1.03M | -25.37%1.25M | -24.06%1.36M | -24.06%1.36M | -32.23%1.36M | -39.55%1.43M | -45.93%1.68M | 898.49%1.8M | 898.49%1.8M |
| -Cash and cash equivalents | -29.04%966.11K | -28.07%1.03M | -25.37%1.25M | -24.06%1.36M | -24.06%1.36M | -32.23%1.36M | -39.55%1.43M | -45.93%1.68M | 898.49%1.8M | 898.49%1.8M |
| Receivables | -45.79%49.77K | -48.00%73.27K | -86.41%1.5K | -68.17%47.27K | -68.17%47.27K | --91.82K | --140.9K | --11.01K | --148.49K | --148.49K |
| -Other receivables | -45.79%49.77K | -48.00%73.27K | -86.41%1.5K | -68.17%47.27K | -68.17%47.27K | --91.82K | --140.9K | --11.01K | --148.49K | --148.49K |
| Total current assets | -30.10%1.02M | -29.86%1.1M | -25.77%1.25M | -27.43%1.41M | -27.43%1.41M | -35.34%1.45M | -41.70%1.57M | -48.37%1.69M | 424.80%1.94M | 424.80%1.94M |
| Non current assets | ||||||||||
| Total non current assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total assets | -30.10%1.02M | -29.86%1.1M | -25.77%1.25M | -27.43%1.41M | -27.43%1.41M | -35.34%1.45M | -41.70%1.57M | -48.37%1.69M | 424.80%1.94M | 424.80%1.94M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -2.97%29.43K | -39.90%23.23K | -44.07%54.86K | -55.85%38.59K | -55.85%38.59K | -73.33%30.33K | -70.22%38.65K | -65.69%98.1K | -59.00%87.42K | -59.00%87.42K |
| -accounts payable | -2.97%29.43K | -39.90%23.23K | -44.07%54.86K | -55.85%38.59K | -55.85%38.59K | -73.33%30.33K | -70.22%38.65K | -65.69%98.1K | -59.00%87.42K | -59.00%87.42K |
| Current liabilities | -2.97%29.43K | -39.90%23.23K | -44.07%54.86K | -55.85%38.59K | -55.85%38.59K | -73.33%30.33K | -70.22%38.65K | -65.69%98.1K | -59.00%87.42K | -59.00%87.42K |
| Non current liabilities | ||||||||||
| Total non current liabilities | 0.00%-1 | ---1 | --0 | --0 | --0 | -200.00%-1 | --0 | --0 | --0 | --0 |
| Total liabilities | -2.97%29.42K | -39.90%23.23K | -44.07%54.86K | -55.85%38.59K | -55.85%38.59K | -73.33%30.33K | -70.22%38.65K | -65.69%98.1K | -59.00%87.42K | -59.00%87.42K |
| Shareholders'equity | ||||||||||
| Share capital | 0.03%4.2M | 0.12%4.2M | 0.28%4.2M | 0.51%4.2M | 0.51%4.2M | 0.81%4.2M | 1.14%4.19M | 1.27%4.19M | 234.56%4.18M | 234.56%4.18M |
| -common stock | 0.03%4.2M | 0.12%4.2M | 0.28%4.2M | 0.51%4.2M | 0.51%4.2M | 0.81%4.2M | 1.14%4.19M | 1.27%4.19M | 234.56%4.18M | 234.56%4.18M |
| Additional paid-in capital | 19.33%1.66M | 13.10%1.64M | 14.90%1.64M | 10.60%1.63M | 10.60%1.63M | -1.83%1.39M | 8.88%1.45M | 17.52%1.42M | 87.32%1.48M | 87.32%1.48M |
| Retained earnings | -17.57%-4.66M | -15.13%-4.53M | -16.54%-4.43M | -19.15%-4.28M | -19.15%-4.28M | -23.30%-3.97M | -39.91%-3.94M | -61.05%-3.8M | -91.29%-3.59M | -91.29%-3.59M |
| Gains losses not affecting retained earnings | -4.82%-205.34K | -32.46%-219.19K | 5.63%-206.91K | 12.96%-174.87K | 12.96%-174.87K | 13.66%-195.9K | -86.91%-165.48K | -66,945.12%-219.25K | ---200.92K | ---200.92K |
| Total stockholders'equity | -30.68%986.46K | -29.60%1.08M | -24.64%1.2M | -26.09%1.37M | -26.09%1.37M | -33.31%1.42M | -40.26%1.54M | -46.71%1.59M | 1,080.92%1.86M | 1,080.92%1.86M |
| Total equity | -30.68%986.46K | -29.60%1.08M | -24.64%1.2M | -26.09%1.37M | -26.09%1.37M | -33.31%1.42M | -40.26%1.54M | -46.71%1.59M | 1,080.92%1.86M | 1,080.92%1.86M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data